
Sign up to save your podcasts
Or


Professor Rob Doughty talks about a new combination medicine to New Zealand for the management of congestive heart failure - ‘Entresto’ Sacubitril/ Valsartan. Rob is a cardiologist and holds the Heart Foundation Chair in Heart Health at the University of Auckland. He practices at Auckland City Hospital where he is the leader of the heart failure service and privately at the Auckland Heart group.
By The Goodfellow Unit (University of Auckland)Professor Rob Doughty talks about a new combination medicine to New Zealand for the management of congestive heart failure - ‘Entresto’ Sacubitril/ Valsartan. Rob is a cardiologist and holds the Heart Foundation Chair in Heart Health at the University of Auckland. He practices at Auckland City Hospital where he is the leader of the heart failure service and privately at the Auckland Heart group.

7,669 Listeners

2,003 Listeners

1,414 Listeners

98 Listeners

3,366 Listeners

112,144 Listeners

271 Listeners

19 Listeners

3 Listeners

999 Listeners

6 Listeners

15,590 Listeners

3,346 Listeners

2,055 Listeners

823 Listeners